Camrelizumab (anti-PD-1)

目录号：A2016         批次号: A201601

打印

Camrelizumab (anti-PD-1)是一种针对PD-1的人源IgG4抗体，抑制PD-L1和PD-L2与PD-1的结合，具有抑制免疫检查点效果和抗肿瘤活性；MW: 146.3 KD。

抗体信息

CAS号 1798286-48-2
配制 PBS buffer, pH 7.2
推荐同型对照 Human IgG4
来源 CHO cells
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99.0%
蛋白浓度 3.9 mg/ml
内毒素 ≤1 EU/mg

Camrelizumab (anti-PD-1)在文献中得到引用

Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathway [ Front Immunol, 2025, 16:1612318] PubMed: 41019041
Variable PD-1 glycosylation modulates the activity of immune checkpoint inhibitors [ Life Sci Alliance, 2024, 7(3)e202302368] PubMed: 38176728

禁止用于人体及治疗！